HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 494 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,267,023 | +10.9% | 10,901 | -1.6% | 0.00% | 0.0% |
| Q2 2023 | $1,142,333 | -79.2% | 11,082 | -78.0% | 0.00% | -75.0% |
| Q1 2023 | $5,491,161 | +11.6% | 50,313 | -36.7% | 0.01% | 0.0% |
| Q3 2022 | $4,921,000 | -24.9% | 79,514 | -3.3% | 0.01% | -27.3% |
| Q2 2022 | $6,556,000 | -3.6% | 82,202 | +27.1% | 0.01% | +22.2% |
| Q1 2022 | $6,804,000 | +102.0% | 64,673 | +106.9% | 0.01% | +80.0% |
| Q4 2021 | $3,368,000 | -41.1% | 31,257 | -40.2% | 0.01% | -37.5% |
| Q3 2021 | $5,723,000 | +443.5% | 52,243 | +364.5% | 0.01% | +700.0% |
| Q2 2021 | $1,053,000 | +3.6% | 11,247 | +1.9% | 0.00% | -50.0% |
| Q1 2021 | $1,016,000 | -49.7% | 11,038 | -60.0% | 0.00% | -50.0% |
| Q4 2020 | $2,018,000 | +44.7% | 27,592 | +53.7% | 0.00% | +33.3% |
| Q3 2020 | $1,395,000 | – | 17,957 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |